Last €5.65 EUR
Change Today -0.002 / -0.04%
Volume 70.0
RMEA On Other Exchanges
Symbol
Exchange
New York
OTC US
Frankfurt
Frankfurt
As of 10:55 AM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

resmed inc-cdi (RMEA) Snapshot

Open
€5.73
Previous Close
€5.65
Day High
€5.87
Day Low
€5.65
52 Week High
01/23/15 - €5.96
52 Week Low
03/25/14 - €3.05
Market Cap
7.9B
Average Volume 10 Days
89.3
EPS TTM
--
Shares Outstanding
1.4B
EX-Date
02/10/15
P/E TM
--
Dividend
€0.11
Dividend Yield
1.52%
Current Stock Chart for RESMED INC-CDI (RMEA)

resmed inc-cdi (RMEA) Related Businessweek News

No Related Businessweek News Found

resmed inc-cdi (RMEA) Details

ResMed Inc. develops, manufactures, distributes, and markets medical equipment for the diagnosis, treatment, and management of respiratory disorders, with a focus on sleep-disordered breathing. Its products portfolio includes airflow generators, diagnostic products, mask systems, motors, and headgear, as well as other accessories, such as cold passover humidifiers, carry bags, and breathing circuits; and humidifiers comprising H5i and H4i, which connect with the continuous and variable positive airway pressure, and AutoSet flow generators to humidify and heat the air delivered to the patient to prevent the drying of nasal passages. The company also offers data communications and control products, including EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. ResMed Inc. markets its products to sleep clinics, home healthcare dealers, and third-party payers. The company sells its products through a network of distributors and direct sales force in approximately 100 countries worldwide. It has a collaboration agreement with Qualcomm Life, Inc. to develop connected health solutions based on 2net and HealthyCircles platforms. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

4,100 Employees
Last Reported Date: 08/8/14
Founded in 1989

resmed inc-cdi (RMEA) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $787.5K
President and Chief Operating Officer
Total Annual Compensation: $664.6K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $494.7K
President of Americas
Total Annual Compensation: $434.6K
Chief Administrative Officer and Global Gener...
Total Annual Compensation: $485.7K
Compensation as of Fiscal Year 2014.

resmed inc-cdi (RMEA) Key Developments

ResMed's AirView Patient Management System to Directly Integrate with Brightree's Home Medical Equipment Billing and Business Management Software Solution

ResMed and Brightree announced ResMed's AirView patient management system will directly integrate with Brightree's leading home medical equipment (HME) billing and business management software solution. The AirView-Brightree integration is the latest connectivity achievement in ResMed and Brightree's longstanding relationship, and is one of multiple enhancements planned for this year. Past advances have included Brightree integration with ResMed's U-Sleep® premium sleep compliance solution, as well as a data exchange agreement allowing HMEs to order ResMed equipment directly from the Brightree platform. This direct integration was made possible by the ResMed Data Exchange program, a comprehensive suite of software and service solutions that allows for the integration of valuable sleep and respiratory treatment data from ResMed's AirView and U-Sleep patient management platforms with electronic medical records, billing, and care management applications. AirView and U-Sleep are part of the ResMed Air Solutions suite of sleep and respiratory products that provide physicians, HMEs and patients with the tools and data that can support improved workflow efficiencies and patient outcomes.

ResMed Inc. Presents at Leerink's Global Healthcare Conference, Feb-12-2015 08:05 AM

ResMed Inc. Presents at Leerink's Global Healthcare Conference, Feb-12-2015 08:05 AM. Venue: Waldorf Astoria New York, New York, New York, United States. Speakers: David Pendarvis, Chief Administrative Officer, Global General Counsel and Secretary.

ResMed Inc. Declares Quarterly Dividend, Payable on March 19, 2015

ResMed Inc. declared a quarterly dividend of $0.28 per share, with a record date of February 12, 2015 and payable on March 19, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RMEA:GR €5.65 EUR -0.002

RMEA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Hologic Inc $32.57 USD -0.11
IDEXX Laboratories Inc $157.04 USD -2.42
Mettler-Toledo International Inc $315.13 USD -2.39
Teleflex Inc $122.28 USD -0.63
Cooper Cos Inc/The $165.02 USD -0.71
View Industry Companies
 

Industry Analysis

RMEA

Industry Average

Valuation RMEA Industry Range
Price/Earnings 26.1x
Price/Sales 5.6x
Price/Book 5.7x
Price/Cash Flow 25.0x
TEV/Sales 4.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RESMED INC-CDI, please visit www.resmed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.